References
  1. Piel FB, Steinberg MH, Rees DC. Sickle Cell Disease. N Engl J Med 2017;377(3):305.
  2. Vilela TS, Braga JAP, Loggetto SR. Hemoglobinopathy and pediatrics in the time of COVID-19. Hematol Transfus Cell Ther2021;43(1):87-100.
  3. Di Nardo M, Hoskote A, Thiruchelvam T, et al. Extracorporeal Membrane Oxygenation in Children with Coronavirus Disease 2019: Preliminary Report from the Collaborative European Chapter of the Extracorporeal Life Support Organization Prospective Survey. ASAIO J2021;67(2):121-24.
  4. Malas MB, Naazie IN, Elsayed N, et al. Thromboembolism risk of COVID-19 is high and associated with a higher risk of mortality: A systematic review and meta-analysis. EClinicalMedicine2020;29:100639.
  5. Kuo KW, Cornell TT, Shanley TP, et al. The use of extracorporeal membrane oxygenation in pediatric patients with sickle cell disease.Perfusion 2013;28(5):424-32.
  6. Ruhl AP, Sadreameli SC, Allen JL, et al. Identifying Clinical and Research Priorities in Sickle Cell Lung Disease. An Official American Thoracic Society Workshop Report. Ann Am Thorac Soc2019;16(9):e17-e32.
  7. Rudym D, Benvenuto L, Costa J, et al. What Awaits on the Other Side: Post-Lung Transplant Morbidity and Mortality After Pre-Transplant Hospitalization. Ann Transplant 2020;25:e922641.